Trueblood Wealth Management, LLC Portfolio Holdings

Trueblood Wealth Management, LLC

  • $256 Billion
  • Q4 2025

Trueblood Wealth Management, LLC has filed its 13F form on January 20, 2026 for Q4 2025 where it was disclosed a total value porftolio of $256 Billion distributed in 252 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Jpmorgan Chase & CO with a value of $13.5B, Apple Inc. with a value of $9.4B, Microsoft Corp with a value of $6.96B, Invesco S&P 500 Equal Weight E with a value of $4.33B, and Nvidia Corp with a value of $4.29B.

Examining the 13F form we can see an decrease of $199M in the current position value, from $256B to 256B.

Trueblood Wealth Management, LLC is based out at Lima, OH

Below you can find more details about Trueblood Wealth Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $256 Billion
ETFs: $66.8 Billion
Technology: $48 Billion
Financial Services: $40.7 Billion
Industrials: $24.1 Billion
Healthcare: $16 Billion
Consumer Cyclical: $11.6 Billion
Energy: $10.2 Billion
Consumer Defensive: $8.87 Billion
Other: $14.4 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$53.5B
$520 Million 0.2% of portfolio
9,736
Q4 2025 Added 1.95%
$0
$496 Million 0.19% of portfolio
8,724
Q4 2025 Added 0.44%
$169B
$496 Million 0.19% of portfolio
3,235
Q4 2025 Added 349.31%
$96.4B
$477 Million 0.19% of portfolio
4,065
Q4 2025 Reduced 3.67%
$0
$499 Million 0.19% of portfolio
4,410
Q4 2025 Added 0.27%
$237B
$449 Million 0.18% of portfolio
2,802
Q4 2025 Added 3.85%
$0
$470 Million 0.18% of portfolio
10,385
Q4 2025 Added 0.45%
Invesco Exchange Traded Fd T
-
$464 Million 0.18% of portfolio
-
Q4 2025 Added 2.27%
$0
$474 Million 0.18% of portfolio
4,299
Q4 2025 Added 3.94%
$0
$467 Million 0.18% of portfolio
3,307
Q4 2025 Added 0.24%
$76.2B
$445 Million 0.17% of portfolio
8,267
Q4 2025 Added 0.01%
$35.1B
$439 Million 0.17% of portfolio
7,790
Q4 2025 Reduced 0.6%
$0
$427 Million 0.17% of portfolio
7,405
Q4 2025 Added 6.13%
$0
$438 Million 0.17% of portfolio
5,179
Q4 2025 Added 0.45%
$0
$426 Million 0.17% of portfolio
3,746
Q4 2025 Added 6.51%
$53.4B
$428 Million 0.17% of portfolio
5,026
Q3 2025 Added 1.39%
$67.3B
$440 Million 0.17% of portfolio
1,517
Q4 2025 Added 0.2%
$147B
$440 Million 0.17% of portfolio
4,612
Q4 2025 Added 0.04%
$328B
$403 Million 0.16% of portfolio
1,307
Q4 2025 Added 12.0%
$418B
$402 Million 0.16% of portfolio
2,740
Q4 2025 Added 3.36%
$193B
$404 Million 0.16% of portfolio
3,552
Q4 2025 Added 0.37%
$24.4B
$406 Million 0.16% of portfolio
2,510
Q4 2025 Reduced 8.06%
$0
$387 Million 0.15% of portfolio
630
Q3 2025 Reduced 14.52%
$0
$375 Million 0.15% of portfolio
4,697
Q4 2025 Added 0.13%
$2.27B
$388 Million 0.15% of portfolio
20,042
Q4 2025 New
$0
$379 Million 0.15% of portfolio
13,868
Q4 2025 Added 1.51%
$136B
$363 Million 0.14% of portfolio
1,568
Q4 2025 Reduced 12.99%
$0
$350 Million 0.14% of portfolio
1,422
Q4 2025 Added 0.21%
$74.3B
$369 Million 0.14% of portfolio
6,131
Q4 2025 Added 0.84%
$61.6B
$348 Million 0.14% of portfolio
12,672
Q4 2025 Added 0.78%
$73.7B
$353 Million 0.14% of portfolio
4,151
Q4 2025 Reduced 7.65%
$0
$352 Million 0.14% of portfolio
3,636
Q4 2025 Added 0.19%
$24.1B
$355 Million 0.14% of portfolio
5,509
Q3 2025 New
$32B
$371 Million 0.14% of portfolio
1,826
Q4 2025 Added 0.27%
$13.2B
$356 Million 0.14% of portfolio
1,480
Q4 2025 Reduced 16.9%
$9.78B
$346 Million 0.13% of portfolio
8,828
Q4 2024 Reduced 1.88%
$11.4B
$343 Million 0.13% of portfolio
2,000
Q2 2024 New
$132B
$328 Million 0.13% of portfolio
1,441
Q4 2025 Added 0.98%
$132B
$325 Million 0.13% of portfolio
1,668
Q4 2025 Reduced 3.64%
Perspective Therapeutics Inc
-
$327 Million 0.13% of portfolio
-
Q4 2025 Added 72.4%
$342B
$310 Million 0.12% of portfolio
1,746
Q4 2025 Added 12.79%
$44.1B
$308 Million 0.12% of portfolio
4,171
Q4 2025 Reduced 4.99%
$181B
$295 Million 0.12% of portfolio
3,613
Q4 2025 Added 13.22%
$74.9B
$307 Million 0.12% of portfolio
1,247
Q4 2025 Reduced 6.52%
$52.5B
$311 Million 0.12% of portfolio
18,846
Q4 2025 Reduced 48.33%
$37.6B
$318 Million 0.12% of portfolio
4,145
Q3 2025 Added 18.23%
$23.5B
$296 Million 0.12% of portfolio
8,088
Q4 2025 Added 0.66%
$181B
$296 Million 0.12% of portfolio
11,904
Q4 2025 Reduced 3.58%
$45.5B
$292 Million 0.11% of portfolio
1,885
Q4 2025 Reduced 15.81%

Summary

  • Portfolio
  • No. of Stocks 252
  • Current Value $256 Billion
  • Prior Value $256 Billion
  • Filing
  • Period Q4 2025
  • Filing Date January 20, 2026
  • Form Type 13F-HR
  • Activity in Q4 2025
  • New Purchases 12 stocks
  • Additional Purchases 139 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 81 stocks
Track This Portfolio

Track Trueblood Wealth Management, LLC Portfolio

Follow Trueblood Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trueblood Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trueblood Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email